Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol and Naltrexone for Opioid Dependence
NCT01024335Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Jan 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dronabinol in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Jan 2010; status: completed.
02
Drugs
dronabinol
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01024335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01024335.